Deals review

Deals review
Deal details

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Vertebroplasty Technology System Focused on Solutions for Vertebral Compression Fractures

Ghent University and Keygene sign AFLP® license agreement

Osmetech licenses VKOR pharmacogenetic marker for warfarin dosage management from University of Washington

Immune Response reaches agreement with Maryland Biotech Institute

Clarient and Health Discovery Corporation Initiate Alliance with Licensing Agreement for New Molecular Diagnostic Test for Prostate Cancer

Dade Behring, Aventis Behring exclusive agreement for FSAP marker

BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University

Dade Behring acquires non-exclusive rights to cardiac marker

More deals

Clients in focus...

Get the Flash Player to see this rotator.

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

Deals review

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology

Related deals

More deals

Latest deals

Most viewed deals

By month